EN PL
 
EN PL
Bieżący numer
Archiwum
Online first
O czasopiśmie
Dla autorów
Książki i Konferencje
6/2017 vol. 55
Pobierz cytowanie
PRACA PRZEGLĄDOWA
Przeciwciała przeciwjądrowe w chorobach autoimmunologicznych i alergicznych
Bogna Grygiel-Górniak
,
 
Natalia Rogacka
,
 
Michał Rogacki
,
 
Mariusz Puszczewicz
 
 
 
Więcej
Ukryj
 
Data nadesłania: 16-11-2017
 
 
Data ostatniej rewizji: 13-12-2017
 
 
Data akceptacji: 14-12-2017
 
 
Data publikacji online: 30-12-2017
 
 
Data publikacji: 31-12-2017
 
 
Reumatologia 2017;55(6):298-304
DOI: https://doi.org/10.5114/reum.2017.72627
 
 
Artykuł (PDF)
Referencje (65)
 
SŁOWA KLUCZOWE
autoimmune diseases
allergy
antinuclear antibodies
molecular background
 
DZIEDZINY
Diagnostyka laboratoryjna I obrazowa chorób reumatycznych
 
STRESZCZENIE
Antinuclear antibodies (ANA) are primarily significant in the diagnosis of systemic connective tissue diseases. The relationship between their occurrence in allergic diseases is poorly documented. However, the mechanism of allergic and autoimmune diseases has a common thread. In both cases, an increased production of IgE antibodies and presence of ANA in selected disease entities is observed. Equally important is the activation of basophils secreting proinflammatory factors and affecting the differentiation of TH17 lymphocytes. Both autoimmune and allergic diseases have complex multi-pathogenesis and often occur in genetically predisposed individuals. The presence of antinuclear antibodies was confirmed in many systemic connective tissue diseases and some allergic diseases. Examples include atopic dermatitis, non-allergic asthma, and pollen allergy. Co-occurring allergic and autoimmune disorders induce further search for mechanisms involved in the aetiopathogenesis of both groups of diseases.
REFERENCJE (65)
1.
Szczeklik A, Nizankowska E, Serafin A, et al. Autoimmune Phenomena in Bronchical Asthma with Special References to Aspirin Intolerance. Am J Respir Crit Care Med 1995; 152: 1753-1756.
Google Scholar
 
 
2.
Nahm DH, Shin MJ, Yim H, et al. Increased levels of circulating autoantibodies to cultured human bronchial epithelial cell in adult patients with nonatopic asthma. J Korean Med Sci 2001; 16: 407-410.
Google Scholar
 
 
3.
Comi AL, Tedeschi A, Lorini M, et al. Novel clinical and serological aspects in non-allergic asthma. Respir Med 2007; 101: 2526-2533.
Google Scholar
 
 
4.
Asero R. Chronic idiopathic urticaria: a family study. Ann Allergy Asthma Immunol 2002; 89: 195-196.
Google Scholar
 
 
5.
Pan Q, Gong L, Xiao H, et al. Basophil Activation-Dependent Autoantibody and Interleukin-17 Production Exacerbate Systemic Lupus Erythematosus. Front Immunol 2017; 27: 348.
Google Scholar
 
 
6.
Atta AM, Sousa CP, Carvalho EM, et al. Immunoglobulin E and systemic lupus erythematosus. Braz J Med Biol Res 2004; 37: 1497-1501.
Google Scholar
 
 
7.
Voehringer D. Recent advances in understanding basophil functions in vivo. F1000Res 2017; 6: 1464.
Google Scholar
 
 
8.
Siracusa MC, KimBS, Spergel JM, et al. Basophils and allergic inflammation. J Allergy Clin Immunol 2013; 132: 788-789.
Google Scholar
 
 
9.
Ochs RL, Muro Y, Si Y, et al. Autoantibodies to DFS 70 kd/transcription coactivator p 75 in atopic dermatitis and other conditions. J Allergy Clin Immunol 2000; 105: 1211-1220.
Google Scholar
 
 
10.
Wakahara K, Baba N, Van V, et al. Human basophils interact with memory T cells to augment Th17 responses. Blood 2012; 120: 4761-4771.
Google Scholar
 
 
11.
Sharma M, Stephen-Victor E, Poncet P, et al. Basophils are inept at promoting human Th17 responses. Hum Immunol 2015; 76: 176-180.
Google Scholar
 
 
12.
Asero R, Madonini E.: Bronchial hyperresponsiveness is a common feature in patients with chronic urticaria. J Investig Allergol Clin Immunol 2006; 16: 19-23.
Google Scholar
 
 
13.
Puszczewicz M, Białkowska-Puszczewicz G, Majewski D. Znaczenie autoprzeciwciał w rozpoznaniu chorób reumatycznych. Postępy Nauk Medycznych 2012; 2: 156-163.
Google Scholar
 
 
14.
Wiik AS, Hoier-Madsen M, Forslid J, et al. Antinuclear antibodies: a contemporary nomenclature using HEp-2 cells. J Autoimmun 2010; 35: 276-290.
Google Scholar
 
 
15.
Puszczewicz M. Przeciwciała przeciwjądrowe – cóż z nimi począć? Reumatologia 2013; 51: 172-178.
Google Scholar
 
 
16.
Tozzoli R, Bonaguri Ch, Melegari A, et al. Current state of diagnostics technologies in the autoimmunology laboratory. Clin Chem Lab Med 2013; 51: 129-138.
Google Scholar
 
 
17.
Bragazzi NL, Watad A, Adawi M, et al. Adjuvants and Autoimmunity: Why Do We Develop Autoantibodies, Autoimmune Diseases and lymphomas. Israel Med Association J 2017; 19: 403-405.
Google Scholar
 
 
18.
Wandstrat A, Carr-Johnson F, Branch V, et al. Autoantibody profiling to identify individuals at risk for systemic lupus erythematosus. J Autoimmun 2006; 27: 153-160.
Google Scholar
 
 
19.
Li QZ, Karp DR, Quan J, et al. Risk factors for ANA positivity in healthy persons. Arthritis Res Ther 2011; 13: R38.
Google Scholar
 
 
20.
Davidson A, Diamond B. Autoimmune diseases. N Engl J Med 2001; 345: 340-350.
Google Scholar
 
 
21.
Fernandez S, Lobo A, Oliveira Z, et al. Prevalence of antinuclear autoantibodies in the serum of normal blood donors. Rev Hosp Clin Fac Med Sao Paulo 2003; 58: 315-319.
Google Scholar
 
 
22.
Semchuk K, Rosenberg A, McDuffie H, et al. Antinuclear antibodies and bromoxynil exposure in a rural sample. J Toxicol Environ Health A 2007; 70: 638-657.
Google Scholar
 
 
23.
Bianchi DW, Wataganara T, Lapaire O, et al. Fetal nucleic acids in maternal body fluids. Ann NY Acad Sci 2006; 1075: 63-73.
Google Scholar
 
 
24.
Grygiel-Górniak B, Puszczewicz MJ. The influence of endogenous and exogenous sex hormones on systemic lupus erythematosus in pre- and postmenopausal women. Prz Menopauzalny 2014; 13: 262-266.
Google Scholar
 
 
25.
Ishikawa M, Konta T, Hao Z, et al. Relationship between antinuclear antibody and microalbuminuria in the general population: the Takahata study. Clin Exp Nephrol 2008; 12: 200-206.
Google Scholar
 
 
26.
Satoh M, Chan EK, Ho LA, et al. Prevalence and sociodemographic correlates of antinuclear antibodies in the United States. Arthritis Rheum 2012; 64: 2319-2327.
Google Scholar
 
 
27.
McGrogan A, Seaman H, Wright J, et al. The incidence of autoimmune thyroid disease: a systematic review of the literature. Clin Endocrinol (Oxf) 2008; 69: 687-696.
Google Scholar
 
 
28.
Vynios DH, Tsagaraki I, Grigoreas GH, et al. Autoantibodies against aggrecan in systemic rheumatic diseases. Biochimie 2006; 88: 767-773.
Google Scholar
 
 
29.
Ruiz JT, Luján L, Blank M, et al. Adjuvants- and vaccines-induced autoimmunity: animal models. Immunol Res 2017; 65: 55-65.
Google Scholar
 
 
30.
Watad A, Quaresma M, Bragazzi NL, et al. The autoimmune/inflammatory syndrome induced by adjuvants (ASIA)/Shoenfeld’s syndrome: descriptive analysis of 300 patients from the international ASIA syndrome registry. Clin Rheumatol 2017; https://doi.org/10.1007/s10067....
CrossRef
 
Google Scholar
 
 
31.
Israeli E, Agmon-Levin N, Blank M, et al. Macrophagic myofaciitis a vaccine (alum) autoimmune-related disease. Clin Rev Allergy Immunol 2011; 41:163-168.
Google Scholar
 
 
32.
Xiao X, Chang C. Diagnosis and classification of drug-induced autoimmunity (DIA). J Autoimmun 2014; 48-49: 66-72.
Google Scholar
 
 
33.
http://www.who.int/mediacentre... [updated April 2017].
Google Scholar
 
 
35.
Johansson SG, Bieber T, Dahl R, el al. Revised nomenclature for allergy for global use: Report of the Nomenclature Review Committee of the World Allergy Organization, October 2003. J Allergy Clin Immunol 2004; 113: 832-836.
Google Scholar
 
 
36.
Szczeklik A. Choroby wewnętrzne. Medycyna Praktyczna. Kraków 2011.
Google Scholar
 
 
37.
Szaflarska A, Rutkowska-Zapała M, Kowalczyk D. Krótka charakterystyka mechanizmów tolerancji immunologicznej. Przegląd Lekarski 2015; 72: 765-769.
Google Scholar
 
 
38.
Male D, Roth DB, Roitt I, et al. Immunologia. Elsevier Urban.
Google Scholar
 
 
39.
& Partner, Wrocław 2008.
Google Scholar
 
 
40.
Gołąb J, Jakóbisiak M, Lasek W, et al. Immunologia. PWN SA. Warszawa 2014.
Google Scholar
 
 
41.
Rose NR. Molecular mimicry and clonal deletion: A fresh look. J Theor Biol 2015; 375: 71-76.
Google Scholar
 
 
42.
Manjarrez-Orduno N, Quach TD, Sanz I. B cells and immunological tolerance. J Invest Dermatol 2009; 129: 278-288.
Google Scholar
 
 
43.
Quintero O, Amador-Patarroyo M, Montoya-Ortiz G, et al. Autoimmune disease and gender: plausible mechanisms for the female predominance of autoimmunity. J Autoimmun 2012; 38: 109-119.
Google Scholar
 
 
44.
Cutolo M, Straub R. Insights into endocrine-immunological disturbances in autoimmunity and their impact on treatment. Arthritis Res Ther 2009; 11: 218.
Google Scholar
 
 
45.
Thai TH, Calado DP, Casola S, et al. Regulation of the germinal center response by microRNA-155. Science 2007; 316: 604-608.
Google Scholar
 
 
46.
Thai TH, Patterson HC, Pham DH, et al. Deletion of micro-.
Google Scholar
 
 
47.
RNA-155 reduces autoantibody responses and alleviates lupus-like disease in the Faslpr mouse. Proc Natl Acad Sci U S A.
Google Scholar
 
 
48.
2013; 110: 20194-20199.
Google Scholar
 
 
49.
Jackson TA, Haga CL, Ehrhardt GR, et al. FcR-like 2 Inhibition of B cell receptor-mediated activation of B cells. J Immunol 2010; 185: 7405-7412.
Google Scholar
 
 
50.
O’Neill SK, Getahun A, Gauld SB, et al. Monophosphorylation of CD79a and CD79b ITAM motifs initiates a SHIP-1 phosphatase-mediated inhibitory signalling cascade required for B cell anergy. Immunity 2011; 35: 746-756.
Google Scholar
 
 
51.
Helgason CD, Kalberer CP, Damen JE, et al. A dual role for Src homology 2 domain-containing inositol-5-phosphatase (SHIP) in immunity: Aberrant development and enhanced function of β lymphocytes in ship -/- mice. J Exp Med 2000; 191: 781-794.
Google Scholar
 
 
52.
Rottem M, Gershwin ME, Shoenfeld Y. Allergic disease and autoimmune effectors pathways. Dcv Immunol 2002; 9: 161-167.
Google Scholar
 
 
53.
Schatz M, Rosenwasser L. The allergic asthma phenotype. J Allergy Clin Immunol Pract 2014; 2: 645-648.
Google Scholar
 
 
54.
Ress K, Metsukla K, Annus T, et al. Antinuclear antibodies in atopic dermatitis: a cross sectional study on 346 children. Int J Dermatol 2015; 54: 24-28.
Google Scholar
 
 
55.
Mahler M, Fritzler MJ. The clinical significance of the dense fine speckled immune-fluorescence pattern on Hep-2 cells for the diagnosis of systematic autoimmune diseases. Clin Dev Immunol 2012; 2012: 494356.
Google Scholar
 
 
56.
Racanelli V, Prete M, Musaraj G, et al. Autoantibodies to intracellular antigens: generation and pathogenetic role. Autoimmun Rev 2011; 10: 503-508.
Google Scholar
 
 
57.
Jabłońska S, Majewski S. Choroby skóry i choroby przenoszone drogą płciową. Wyd. Lekarskie PZWL, Warszawa 2008.
Google Scholar
 
 
58.
Higashi N, Niimi Y, Aoki M, et al. Clinical features of antinuclear antibody-positive patients with atopic dermatitis. J Nippon Med Sch 2009; 76: 300-307.
Google Scholar
 
 
59.
Mittermann I, Aichberger KJ, Bünder R, et al. Autoimmunity and atopic dermatitis. Curr Opin Allergy Clin Immunol 2004; 4: 367-371.
Google Scholar
 
 
60.
Tang TS, Bieber T, Williams HC. Does the autoreactivity play a role in atopic dermatitis? J Allergy Clin Immunol 2012; 129: 1209-1215.
Google Scholar
 
 
61.
Valenta R, Seiberler S, Natter S, et al. Autoallergy: A pathogenetic factor in atopic dermatitis? J Allergy Clin Immunol 2000; 105: 432-437.
Google Scholar
 
 
62.
Noack M, Miossec P. Selected cytokine pathways in rheumatoid arthritis. Semin Immunopathol 2017; 39: 365-383.
Google Scholar
 
 
63.
Yoshimoto T, Nakanishi K. Generation and characterization of mouse basophils from bone marrow and purification of basophils from spleen. Curr Protoc Immunol 2012; Chapter 3: Unit 3.24.
Google Scholar
 
 
64.
Lidor Y, Topilsky M, Spitzer SA, et al. Autoimmune antibodies in intrinsic (non-atopic) asthma. Ann Allergy 1980; 44: 296-298.
Google Scholar
 
 
65.
Agache I, Duca L, Anghel M. Antinuclear antibodies in asthma patients – a special asthma phenotype? Iran J Allergy Asthma Immunol 2009; 8: 49-52.
Google Scholar
 
 
Copyright: © Narodowy Instytut Geriatrii, Reumatologii i Rehabilitacji w Warszawie. This is an Open Access journal, all articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License (https://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
Udostępnij
Wyślij mailem
ARTYKUŁ POWIĄZANY
Multisystem inflammatory syndrome – a rare but serious complication of Clostridioides difficile infection in children
Clinical and laboratory differences in paediatric-onset versus adult-onset lupus nephritis among patients with systemic lupus erythematosus: a retrospective cohort analysis
Co-occurrence of rheumatic autoimmune disorders with selective immunoglobin A deficiency
Autoimmune diseases and myelodysplastic syndromes
Artykuł przeglądowy
Przeciwciała przeciwjądrowe w twardzinie układowej – charakterystyka antygenowa i znaczenie kliniczne
Indeksy
 
Indeks słów kluczowych
Indeks dziedzin
Indeks autorów
eISSN:2084-9834
ISSN:0034-6233
Journals System - logo
© 2006-2024 Journal hosting platform by Bentus
Scroll to top